Research Topics
Species | H WildiersSummaryAffiliation: University Hospitals Leuven Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric OncologyHans Wildiers
Department of General Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
Lancet Oncol 8:1101-15. 2007..The available evidence was reviewed and synthesised to provide consensus recommendations regarding the care of breast cancer in older adults...
Issues in the adjuvant treatment of common tumors (with a focus on breast cancer) in older adults (age >70)H Wildiers
Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
Ann Oncol 23:x339-41. 2012..age-related physiological changes can decrease tolerance of classical chemotherapy regimens, indicating the need for close monitoring and preventive measures...
Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequenceH Wildiers
Multidisciplinary Breast Center, University Hospitals Leuven, Leuven, Belgium
Breast Cancer Res Treat 114:103-12. 2009....
A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patientsHans Wildiers
Multidisciplinary Breast Centre, University Hospital Gasthuisberg, KU Leuven, Belgium
Crit Rev Oncol Hematol 67:133-8. 2008..SRI may be a useful tool in the follow-up of elderly patients treated with anthracyclines, allowing early initiation of preventive measures in order to prevent further irreversible cardiac damage...
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphomaHans Wildiers
Multidisciplinary Breast Centre, University Hospital Gasthuisberg, Leuven, Belgium
Crit Rev Oncol Hematol 77:221-40. 2011..The definition of "full dose" is, however, unclear. Older age and higher disease stage may be associated with reduced RDI, and G-CSF improved the chances of higher RDI in most studies...
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancerH Wildiers
Department of General Medical Oncology Multidisciplinary Breast Centre, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
Breast Cancer Res Treat 123:463-9. 2010..Furthermore, toxicity was significant...
Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracycline-based chemotherapy regimen for patients with locally advanced breast cancerH Wildiers
Department of General Medical Oncology, University Hospitals Leuven, Herestraat 49, B 3000 Leuven, Belgium
Ann Oncol 22:588-94. 2011..To evaluate capecitabine-docetaxel (XT), with trastuzumab (H) in human epidermal growth factor receptor 2 (HER2)-positive disease, in inoperable locally advanced breast cancer (LABC)...
Mastering chemotherapy dose reduction in elderly cancer patientsHans Wildiers
Department of General Medical Oncology Multidisciplinary Breast Centre, University Hospital Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
Eur J Cancer 43:2235-41. 2007..Each of these topics will be reviewed here trying to give concrete recommendations for clinical practice...
Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal careHans Wildiers
Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
J Pain Symptom Manage 38:124-33. 2009..9 hours. These data suggest that there are no significant differences in effectiveness or survival time among atropine, hyoscine butylbromide, and scopolamine in the treatment of death rattle...
Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancerB Brouwers
Multidisciplinary Breast Centre, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
Tumour Biol 29:211-6. 2008..It is mainly a clinical diagnosis. The aim of this study was to compare IBC to clinically diagnosed noninflammatory locally advanced nonmetastatic breast cancer, also called cLABC...
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersO Brouckaert
Multidisciplinary Breast Centre, University Hospital Leuven, Leuven, Belgium
Ann Oncol 23:2578-84. 2012..We here applied the 2011 St Gallen surrogate definition for breast cancer subclassification using tumor grade instead of Ki67...
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAsA Smeets
Multidisciplinary Breast Centre University Hospital, Herestraat 49, B 3000 Leuven, Belgium
Breast Cancer Res Treat 129:767-76. 2011..Moreover, our data suggest a general deregulation of the miRNA machinery that is potentially responsible for lymph node invasion...
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patientsT Vandorpe
Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium
Breast Cancer Res Treat 128:429-35. 2011..The mildly higher incidence of ALN metastasis in lobular cancers in univariable analysis is not due to the lobular subtype, but due to confounding factors that interact with lymph node involvement...
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancerP Neven
Department of Obstetrics and Gynaecology, Multidisciplinary Breast Centre, University Hospitals Leuven, Herestraat 49, B 3000 Leuven, Belgium
Breast Cancer Res Treat 110:153-9. 2008..The negative association between the oestrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER-2) in breast cancer travels in both directions. ER+ tumours are less likely HER-2+ and HER-2+ tumours are less likely ER+...
Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1S Pintens
Department of Pathology, UZ Leuven, Leuven, Belgium
J Clin Pathol 62:624-8. 2009..The aim of this study was to investigate to what extent CK5/6 and HER-1 characterise the group of triple negative breast cancers...
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up dataA Lintermans
Department of Obstetrics and Gynecology, KU Leuven, Leuven, Belgium
Ann Oncol 24:350-5. 2013..Looking into its pathophysiology, 6 months of AI therapy thickens the tendon sheath with intra-articular fluid (IAF) retention and loss of grip strength. We here report 24-month follow-up data...
Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of viewP Neven
Multidisciplinary Breast Center Department of Obstetrics and Gynecology, UZ Leuven, Catholic University Leuven, Leuven, Belgium
Int J Gynecol Cancer 16:505-10. 2006
Matrix metalloproteinase expression patterns in luminal A type breast carcinomasJ Decock
Laboratory for Experimental Oncology LEO, Department of General Medical Oncology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
Dis Markers 23:189-96. 2007..The current study aimed at defining an RNA expression profile of various MMPs in breast cancer and correlating their expression with clinicopathological parameters...
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of ageT Van Mieghem
Department of Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium
Breast Cancer Res Treat 106:127-33. 2007..It is unknown whether circulating estrogens affect HER-2 expression. We hypothesize that the postmenopausal body mass index (BMI) as a surrogate marker for bio-available estrogens, is inversely associated with HER-2 over-expression...
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans
Department of Obstetrics and Gynecology, Division of Gynecological Oncology, University Hospitals Leuven, Belgium
Ann Oncol 22:1763-9. 2011..Here, we report the final results and assess the relationship between grip strength and body mass index (BMI)...
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen usersA S Dieudonné
Department of Obstetrics and Gynecology, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium
Breast Cancer Res Treat 118:531-8. 2009..They support clinical trials prospectively testing the effect of CYP2D6 genetic variability in response to tamoxifen before denying this drug to breast cancer patients only based on their CYP2D6*4 status...
A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosisB Leyssens
Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium
Ann Oncol 21:419-23. 2010..We investigate the efficacy of eyedrops containing corticosteroids (CS) versus artificial tears (AT) in patients receiving weekly docetaxel in the prevention of dacryostenosis...
Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variablesJ Decock
Laboratory for Experimental Oncology (LEO, Department of General Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
Clin Exp Metastasis 22:495-502. 2005..However, this increase was too small to be of clinical use. Furthermore, no relationship was found between plasma gelatinase levels, total or active, and any of the clinicopathological prognostic factors...
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancerR Paridaens
Department of General Medical Oncology, Leuven Cancer Institute, University Hospitals Borst Centrum, Belgium
Cancer Chemother Pharmacol 70:503-11. 2012..To determine the recommended dose (RD) of vinflunine in combination with trastuzumab in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) and to investigate potential pharmacokinetic (PK) interactions...
Challenges in treating older cancer patients: breast cancerH Wildiers
Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
Ann Oncol 19:vii99-103. 2008
Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancerRuxandra Jurcut
Department of Cardiovascular Diseases, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium
J Am Soc Echocardiogr 21:1283-9. 2008..Doppler myocardial imaging-based velocity, strain, and strain rate measurements have been shown to sensitively quantify abnormalities in cardiac function in other settings...
Pharmacology of anticancer drugs in the elderly populationHans Wildiers
Laboratory of Experimental Oncology, and Department of Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
Clin Pharmacokinet 42:1213-42. 2003..This review attempts to elucidate the factors that can influence the pharmacokinetics of anticancer drugs frequently used in the elderly, and the clinical or biochemical parameters that form the basis for dose adjustments with age...
Detection and monitoring of cardiotoxicity-what does modern cardiology offer?Ruxandra Jurcut
Department of Cardiology, University Hospital Gasthuisberg, Catholic University Leuven, Herestraat 49, 3000, Leuven, Belgium
Support Care Cancer 16:437-45. 2008..The use of new biomarkers like B-type natriuretic peptide and troponin and less often used imaging techniques like magnetic resonance imaging and computed tomography will also be mentioned...
Triple-negative breast cancerGert Stockmans
Department of Internal Medicine, University Hospital Gasthuisberg, Herestraat, Leuven, Belgium
Curr Opin Oncol 20:614-20. 2008..We would like to describe recent pathological and genetic advancements and their possible implications on the development of new treatment strategies...
Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequenceH Wildiers
Laboratory of Experimental Oncology, University Hospital Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
Eur J Cancer 40:284-90. 2004..Mechanisms other than trapping are likely to be involved in the chemosensitising capacity of CA4DP...
Adjuvant chemotherapy in elderly patients with breast cancer: where are we?Hans Wildiers
Department of Medical Oncology, University Hospital Gasthuisberg, Catholic University of Leuven, Belgium
Curr Opin Oncol 17:566-72. 2005..This review summarizes the current knowledge and provides guidelines for the use of adjuvant chemotherapy in elderly patients with breast cancer...
Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical OncologyBenoit Beuselinck
Medical Oncology Department, Catholic University Leuven, University Hospitals Leuven, Herestraat 49, Leuven, Belgium
Crit Rev Oncol Hematol 75:70-7. 2010..They display different, but acceptable toxicity profiles, with levels of antitumoral efficacy comparable to those previously reported for 3-weekly regimens...
Taxanes in elderly breast cancer patientsHans Wildiers
Department of Oncology, University Hospital Gasthuisberg, Catholic University of Leuven, Herestraat 49, Leuven B 3000, Belgium
Cancer Treat Rev 30:333-42. 2004..In general however, weekly taxanes are a reasonable option for older patients with metastatic breast cancer...
Safety and efficacy of weekly docetaxel in frail and/or elderly patients with metastatic breast cancer: a phase II studyRobert Paridaens
Department of Oncology, University Hospital Gasthuisberg, Catholic University of Leuven, Leuven, Belgium
Anticancer Drugs 15:341-6. 2004....
Relationship between age and axillary lymph node involvement in women with breast cancerHans Wildiers
Multidisciplinary Breast Centre and Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium
J Clin Oncol 27:2931-7. 2009..To study the relation between the presence of axillary lymph node (LN) involvement and age in breast cancer...
Death rattle: prevalence, prevention and treatmentHans Wildiers
Department of Oncology, Gasthuisberg University Hospital Leuven, Leuven, Belgium
J Pain Symptom Manage 23:310-7. 2002..Administration of subcutaneous hyoscine hydrobromide, as a bolus or continuous infusion, is effective therapy for real DR and is comfortable for the patient and caregivers...
Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrantLeilani Morales
Department of Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
Breast Cancer Res Treat 117:77-81. 2009..Furthermore, no new uterine pathologies were detected, indicating that fulvestrant behaves as a pure antiestrogen at the uterine level...
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positiveBen Van Calster
Multidisciplinary Breast Centre, UZ Leuven, Herestraat 49, 3000 Leuven, Belgium
Breast Cancer Res Treat 113:181-7. 2009..To examine the frequency of axillary lymph node (ALN) invasion of operable breast cancers by their combined oestrogen receptor (ER), progesterone receptor (PR) and HER-2 status...
Intra-hepatic Mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancerToon Maes
Department of General Medical Oncology, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
Breast Cancer Res Treat 110:135-42. 2008..In the treatment of extensive liver metastasis of breast cancer (LMBC), locally administered Mitomycin C (MMC) to the liver might be an effective approach with limited toxicity...
Unexpected interactions between nicotinamide and CPT-11 in a rhabdomyosarcoma tumor modelHans Wildiers
Laboratory of Experimental Oncology LEO, University Hospital Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
Anticancer Res 23:4055-9. 2003..Great care is required when combining nicotinamide with anticancer drugs, since unexpected pharmacokinetic and pharmacodynamic alterations might occur...
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptorsOlivier Brouckaert
Multidisciplinary Breast Centre, UZLeuven, Leuven 3000, Belgium
Breast Cancer Res Treat 115:349-58. 2009..We here report the short-term disease-free interval (DFI) of operable breast cancers by their joint hormone receptor/HER-2 phenotype...
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imagingLeilani Morales
Department of General Medical Oncology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
Breast Cancer Res Treat 104:87-91. 2007..However, the pathogenesis and anatomic correlate of musculoskeletal pains have not been thoroughly evaluated. Moreover, the impact of AI-induced musculoskeletal symptoms on normal daily functioning needs to be further explored...
Fertility preservation in (breast) cancer patients: is it safe?Hans Wildiers
J Clin Oncol 24:5335-6; author reply 5337-8. 2006
International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiencyStuart M Lichtman
Memorial Sloan Kettering Cancer Centre, New York, USA
Eur J Cancer 43:14-34. 2007..Pharmacokinetic and pharmacodynamic data of anticancer agents in the elderly are needed in order to maximise efficacy whilst avoiding unacceptable toxicity...
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancerRobert Paridaens
Universitair Ziekenhuis Gasthuisberg, Katholieke Universiteit Leuven, Belgium
Clin Breast Cancer 7:861-6. 2007..Pemetrexed and epirubicin are each active in patients with advanced/metastatic breast cancer (MBC). This phase I/II study evaluated these drugs as a combination regimen...
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-relatedHuei-Jean Huang
Division of Gynaecologic Oncology in Department of Obstetrics and Gynaecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Breast Cancer Res Treat 91:81-7. 2005..518). The study confirms an age-related inverse relationship between HER-2/neu and PR only in women age>45 years but not in women age<or=45 years...
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literatureStuart M Lichtman
Memorial Sloan Kettering Cancer Center, Commack, New York 11725, USA
J Clin Oncol 25:1832-43. 2007..In addition, data already accumulated need to be reanalyzed by age to aid in the management of the older cancer patient...
Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCRMohamed Saad Ismail
Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium and National Cancer Institute, Cairo, Egypt
Clin Cancer Res 10:196-201. 2004..However, no significant correlation between the presence of CK19+ cells in BM and PB and classical prognostic factors was found. We detected no statistically significant influence of surgical manipulation on CK19+ cells...
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?Leen De Maeyer
J Clin Oncol 26:335-6; author reply 336-8. 2008
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvementPatrick Neven
J Clin Oncol 26:1768-9; author reply 1769-71. 2008
